Cannabidiol - an in Vivo Innovative Drug Delivery Study

Inclusion Criteria: * Informed consent given by the subject * Negative drug screening at the time of screening * Non-smoking * In female participants in fertile age, reliable contraception, which means contraception's Pearl index is equal to or smaller than 1. * Body Mass Index between 18.5 kg/m2 and 30 kg/m2 Exclusion Criteria: * Lack of accountability * Pregnancy or lactation phase in females at the time of screening * Any known psychiatric or neurological illness in the participant's history. * Known family history regarding psychiatric disorders with an increased lifetime risk for psychiatric disorders in the participant (investigators qualified judgement) * Relevant use of cannabis (which is defined on the present state of knowledge as more than five times lifetime consumption and/or more than two consumptions during the last year) * Consumption of any illicit drugs (except cannabis in history, see above) * Severe physical (internal) or neurological illness, especially cardiovascular, renal, advanced respiratory, haematologic or endocrinologic disorders or infectious diseases (acute hepatitis A, B or C or HIV) assessed at the time of the screening by the subject's history, clinical examination and laboratory testing, as assessed by the investigator